DaVita (DVA)
(Delayed Data from NYSE)
$148.88 USD
+3.04 (2.08%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $149.50 +0.62 (0.42%) 7:58 PM ET
2-Buy of 5 2
A Value C Growth B Momentum A VGM
Brokerage Reports
DaVita Inc. [DVA]
Reports for Purchase
Showing records 81 - 100 ( 289 total )
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Provider: Zacks Investment Research
Analyst: Research Department
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Provider: Zacks Investment Research
Analyst: Research Department
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Provider: Zacks Investment Research
Analyst: Research Department
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Provider: Zacks Investment Research
Analyst: Research Department
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Provider: Zacks Investment Research
Analyst: Research Department
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Provider: Zacks Investment Research
Analyst: Research Department
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Provider: Zacks Investment Research
Analyst: Research Department
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Provider: Zacks Investment Research
Analyst: Research Department
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Provider: Zacks Investment Research
Analyst: Research Department
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Provider: Zacks Investment Research
Analyst: Research Department
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Provider: Zacks Investment Research
Analyst: Research Department